Publications in collaboration with researchers from University of Cambridge (5)

2025

  1. Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 21, Núm. 7, pp. e70309

2021

  1. Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study

    The Lancet Neurology, Vol. 20, Núm. 9, pp. 709-720

2020

  1. Magnetisation transfer ratio abnormalities in primary and secondary progressive multiple sclerosis

    Multiple Sclerosis Journal, Vol. 26, Núm. 6, pp. 679-687

  2. Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab

    Multiple Sclerosis Journal, Vol. 26, Núm. 9, pp. 1093-1101

2019

  1. Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 166, Núm. 22, pp. 11020-11027